Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06606210 · ClinicalTrials.gov registry record · NA
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
A NA study of Venous Leg Ulcer and Wound Heal, sponsored by ConvaTec.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06606210: Recruiting NA study of Venous Leg Ulcer and Wound Heal, sponsored by ConvaTec.
NCT06606210 is a NA study of Venous Leg Ulcer and Wound Heal that is actively recruiting participants, run by ConvaTec. The registered enrollment target is 120 participants, below the 242-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06606210, a NA study of Venous Leg Ulcer and Wound Heal, is actively recruiting participants, sponsored by ConvaTec.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
INNOVEN is a multi-center randomized controlled clinical trial to evaluate the efficacy of porcine placental extracellular matrix (PPECM) and standard of care (SOC) versus SOC alone in the closure of non-healing venous leg ulcers (VLUs).
Primary Outcome
The percentage of target ulcers achieving complete wound closure defined as complete epithelialisation of the wound surface.
Conditions Studied
Interventions
- DEVICE InnovaMatrix® AC
Study Locations (1)
Florida
- Three Rivers Wound and Hyperbaric Center - North Port
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-09-19 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT06606210 shows while recruiting
NCT06606210 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 242-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 1 intervention - of which InnovaMatrix® AC is the first listed.
NCT06606210 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06606210 about?
NCT06606210 is a clinical study titled "INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone". INNOVEN is a multi-center randomized controlled clinical trial to evaluate the efficacy of porcine placental extracellular matrix (PPECM) and standard of care (SOC) versus SOC alone in the closure of non-healing venous leg ulcers (VLUs).
What is the current status of trial NCT06606210?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-09-19. Estimated completion is 2026-04.
What conditions does trial NCT06606210 study?
This clinical trial studies the following conditions: Venous Leg Ulcer, Wound Heal.
What interventions are being tested in trial NCT06606210?
The interventions under investigation include: InnovaMatrix® AC (DEVICE).
Who is sponsoring clinical trial NCT06606210?
This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06606210 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06606210's enrollment target sits among peer trials
120 22nd of 35 higher than 13 of 35 other Venous Leg Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
-
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · NA
-
Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers Using Near Infrared Laser Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI